Cancer treatment increasingly depends on understanding the specific genetic changes driving a tumor, not just where it started or what it looks like under a microscope. Genomic testing, from targeted gene panels to whole-genome sequencing, helps match patients with treatments suited to their specific cancer. Additionally, tracking minimal residual disease (MRD), the small pockets of cancer cells that linger after treatment, helps therapies evolve to avoid relapse.
Download this eBook to see where oncology is heading next and learn how sequencing and residual disease monitoring are changing the way scientists diagnose and track cancer.